
U.S. approves breakthrough pancreatic cancer drug, heralding a new era for an intractable disease
Pancreatic cancer is considered one of the hardest to treat and most serious forms of cancer

U.S. approves breakthrough pancreatic cancer drug, heralding a new era for an intractable disease
Pancreatic cancer is considered one of the hardest to treat and most serious forms of cancer

‘Landmark’ trial shows mRNA therapy significantly cuts the odds of recurrent skin cancer
The combined drug works by nudging the body’s own immune system to make proteins that attack and destroy melanoma cells


Experimental immune therapy shows promise against deadly childhood brain cancer
Several children who had aggressive recurrent brain tumors remained disease-free years after this treatment, according to an early-stage trial

How viruses may reshape the body’s ‘soil’ to promote cancer growth
Everyday viral infections may be quietly reshaping the body’s network of molecules that support cells and tissues in ways that can raise cancer risk over time

Proposed White House regulations could kill 5,000 clinical trials, analysis finds
The Trump administration is mulling new rules that would give political appointees final say on research grants

Jaye Gardiner
Learning how the matrix around cells and tissues impacts cancers

Mikhail Kolmogorov
Developing software to reveal large genetic changes that lead to cancer

Chris Boshoff
The Pfizer executive talks about rekindling the public’s excitement over science

U.S. gets a new sunscreen ingredient after 27 years—here’s how it works
Dermatologists and skincare aficionados are excited for the U.S. to finally get a new, more protective sunscreen filter after more than 20 years of regulatory roadblocks. Here’s how bemotrizinol works

Why drugs like Ozempic might reduce cancer risk
A new wave of research links GLP-1 drugs to reduced cancer spread and better survival, and the mechanism may go beyond just weight loss

How breast cancer screening can predict heart disease risk
AI analysis of mammograms could provide a “bonus finding” for heart disease

Landmark pancreatic cancer treatment paves way for targeting other tricky tumors
Unprecedented results against a stubbornly hard-to-treat cancer are boosting optimism that other challenging tumors will be next